New England Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-850
Closed -$74K 167
2021
Q4
$74K Sell
850
-1,400
-62% -$116K ﹤0.01% 164
2021
Q3
$184K Hold
2,250
﹤0.01% 152
2021
Q2
$205K Hold
2,250
﹤0.01% 128
2021
Q1
$192K Hold
2,250
﹤0.01% 137
2020
Q4
$212K Hold
2,250
﹤0.01% 126
2020
Q3
$196K Hold
2,250
﹤0.01% 128
2020
Q2
$197K Hold
2,250
﹤0.01% 125
2020
Q1
$186K Hold
2,250
﹤0.01% 126
2019
Q4
$213K Hold
2,250
﹤0.01% 134
2019
Q3
$196K Hold
2,250
﹤0.01% 137
2019
Q2
$205K Sell
2,250
-261
-10% -$22.1K ﹤0.01% 137
2019
Q1
$216K Hold
2,511
﹤0.01% 139
2018
Q4
$193K Hold
2,511
﹤0.01% 137
2018
Q3
$194K Hold
2,511
﹤0.01% 187
2018
Q2
$170K Hold
2,511
﹤0.01% 192
2018
Q1
$182K Hold
2,511
﹤0.01% 126
2017
Q4
$189K Hold
2,511
﹤0.01% 124
2017
Q3
$193K Hold
2,511
﹤0.01% 119
2017
Q2
$188K Hold
2,511
0.01% 112
2017
Q1
$167K Sell
2,511
-1,451
-37% -$96.7K ﹤0.01% 140
2016
Q4
$259K Buy
3,962
+1,451
+58% +$94.1K 0.01% 128
2016
Q3
$178K Hold
2,511
0.01% 135
2016
Q2
$186K Hold
2,511
0.01% 119
2016
Q1
$163K Hold
2,511
0.01% 126
2015
Q4
$194K Hold
2,511
﹤0.01% 123
2015
Q3
$207K Hold
2,511
0.01% 114
2015
Q2
$221K Hold
2,511
0.01% 112
2015
Q1
$222K Buy
+2,511
New +$223K 0.01% 123

Other funds holding NVS

New England Asset Management's NVS Position: Q1 2022 in Review

New England Asset Management sold out of Novartis (NVS) in Q1 2022, closing a stake of 850 shares — an estimated $74K sold.

New England Asset Management first reported a position in NVS in Q1 2015 and held it in 28 quarters. The position peaked at $259K in Q4 2016. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

  • New England Asset Management reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
  • New England Asset Management sold 850 Novartis shares in Q1 2022, an estimated $74K.
  • New England Asset Management first reported a position in Novartis in Q1 2015 and held it in 28 quarters.
  • New England Asset Management's Novartis position peaked at $259K in Q4 2016.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on New England Asset Management's 13F filing for Q1 2022, filed 16 May 2022.